Oncotype DX recurrence score implications for disparities in chemotherapy and breast cancer mortality in Georgia

Among women diagnosed with stage I–IIIa, node-negative, hormone receptor (HR)-positive breast cancer (BC), Oncotype DX recurrence scores (ODX RS) inform chemotherapy treatment decisions. Differences in recurrence scores or testing may contribute to racial disparities in BC mortality among women with...

Descripción completa

Detalles Bibliográficos
Autores principales: Collin, Lindsay J., Yan, Ming, Jiang, Renjian, Ward, Kevin C., Crawford, Brittany, Torres, Mylin A., Gogineni, Keerthi, Subhedar, Preeti D., Puvanesarajah, Samantha, Gaudet, Mia M., McCullough, Lauren E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763428/
https://www.ncbi.nlm.nih.gov/pubmed/31583272
http://dx.doi.org/10.1038/s41523-019-0129-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763428/
https://www.ncbi.nlm.nih.gov/pubmed/31583272
http://dx.doi.org/10.1038/s41523-019-0129-3

Ejemplares similares